State Street Corp Capricor Therapeutics, Inc. Transaction History
State Street Corp
- $2.25 Trillion
- Q2 2024
A detailed history of State Street Corp transactions in Capricor Therapeutics, Inc. stock. As of the latest transaction made, State Street Corp holds 401,022 shares of CAPR stock, worth $7.31 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
401,022
Previous 116,724
243.56%
Holding current value
$7.31 Million
Previous $792,000
141.41%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding CAPR
# of Institutions
70Shares Held
6.3MCall Options Held
210KPut Options Held
374K-
Black Rock Inc. New York, NY1.63MShares$29.7 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.55MShares$28.2 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA642KShares$11.7 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny480KShares$8.74 Million0.0% of portfolio
-
Advisor Group Holdings, Inc. Phoenix, AZ162KShares$2.96 Million0.0% of portfolio
About CAPRICOR THERAPEUTICS, INC.
- Ticker CAPR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 24,346,200
- Market Cap $444M
- Description
- Capricor Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the development of transformative cell and exosome-based therapeutics for the treatment and prevention of spectrum of diseases and disorders. Its lead candidate, CAP-1002, an allogeneic cardiac-derived cell therapy, which has completed phase III clinical trial for th...